Top 5 Most Listened-to Podcasts of 2023
Throughout 2023, guests of the Applied Clinical Trials podcast spoke on a number of topics including clinical research in rare disease areas, data, and artificial intelligence.
Below is a list of the most listened-to episodes of the Applied Clinical Trials Podcast in 2023.
1. IndoUSrare: Purposeful Clinical Research For Rare Diseases In India
Dr. Harsha Rajasimha, Founder and Chairman of IndoUSrare, discusses the emotional reason behind founding the non-profit, programs they offer that are helping rare disease parents/patients, rare disease research in India, and much more.
Listen to the episode here.
2. Data In Clinical Trials—How Did We Get Here And What’s Next?
Gabriele Brambilla, CEO of Alira Health, discusses how data sharing in clinical research should be implemented to value the person. He also highlights his career path and how he became so interested in healthcare innovation.
Listen to the episode here.
3. The Evolution of Early-phase Research
Colleen Hoke, Co-Founder and CEO of ObjectiveHealth discusses her career in early-phase research and the transition from working with a startup to a major research organization. She also touches on what her current company, ObjectiveHealth is working on, leadership skills, and the evolution of clinical research.
Listen to the episode here.
4. Building Clinical Trials with Trust
Charlotte Grayson, MD, clinical research medical director, Privia Health highlights her journey to becoming a physician and eventually getting involved with clinical trials. She also discusses what integrated research organizations (IROs) are now bringing to the table and how they are effective in enrollment and building patient-physician relationships.
Listen to the episode here.
5. Leveraging The Power Of AI
Najat Khan, PhD, chief data science officer and global head, strategy, portfolio & operations, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson shares her career path and how she became interested in clinical data. She also discusses some current trends in artificial intelligence/machine learning such as utilizing them in drug discovery and making clinical trials more inclusive.
Listen to the episode here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Industry Assessment of Risk-Based Quality Management Emphasizes Value of Adoption
April 4th 2024A study conducted by the Tufts CSDD in collaboration with CluePoints and PwC revealed that slightly more than half of sponsors and contract research organizations have adopted risk-based quality management approaches.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.
